NCT04902170

Brief Summary

This study aimed to compare the safety and efficacy of vitrectomy probe with different shaft lengths in vitreoretinal surgery of highly myopic patients. In this randomized controlled study, highly myopic patients who had axial length more than 26 mm and needed vitreoretinal surgery will be enrolled. The enrolled patients will be randomized into "30 mm shaft length group"(trial group) and "27mm shaft length group"(controlled group). We will compare the rate of wound leakage, hypotony, subconjunctival hemorrhage, probe bending, trocar removal, and endophthalmitis between the two groups. We would like to evaluate the efficacy and safety of the 30 mm shaft length vitrectomy probe.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 26, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 22, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2023

Completed
Last Updated

June 18, 2023

Status Verified

November 1, 2021

Enrollment Period

11 months

First QC Date

February 21, 2021

Last Update Submit

June 14, 2023

Conditions

Keywords

High myopiaPars plana vitrectomyVitreoretinal disease

Outcome Measures

Primary Outcomes (2)

  • trocar removal rate

    trocar removal would be performed if the length of vitrectomy probe was not adequate

    intra-operative

  • operation time

    record the operation time and time of core vitrectomy

    intra-operative

Secondary Outcomes (1)

  • instrument bending

    intraoperative

Other Outcomes (4)

  • Complications

    Until post-op 6 month

  • wound status evaluation by slit lamp biomicroscopy

    until post-op 1 month

  • anatomical success evaluation by optical coherence tomography and indirect ophthalmolscopy

    post-op 3 month

  • +1 more other outcomes

Study Arms (2)

study group

EXPERIMENTAL

Highly myopic patients with vitreoretinal disease requiring pars plana vitrectomy. The 30mm (shaft length) vitrectomy probe (25 gauge) would be used in the surgery.

Procedure: 25 gauge pars plana vitrectomy

control group

ACTIVE COMPARATOR

Highly myopic patients with vitreoretinal disease requiring pars plana vitrectomy. The 27mm (shaft length) vitrectomy probe (25 gauge) would be used in the surgery.

Procedure: 25 gauge pars plana vitrectomy

Interventions

25 gauge pars plana vitrectomy

control groupstudy group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Highly myopic patients (axial length \> 26mm) with vitreoretinal diseases or maculopathy requiring pars plana vitrectomy

You may not qualify if:

  • Previous history of pars plana vitrectomy
  • Surgical plan combining encircling buckle
  • Silicone oil or perfluorocarbon liquid use intraoperatively
  • Previous history of pterygium surgery, trabeculectomy, glaucoma surgery
  • Previous history of corneal, conjunctival, or scleral laceration
  • History of connective tissue disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Tzyy-Chang Ho

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2021

First Posted

May 26, 2021

Study Start

July 22, 2021

Primary Completion

June 17, 2022

Study Completion

February 7, 2023

Last Updated

June 18, 2023

Record last verified: 2021-11

Locations